ALAB Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Astera Labs Inc (ALAB) is not a strong buy at the moment for a beginner investor with a long-term focus. The stock is currently in a bearish trend, with declining price momentum and no immediate positive trading signals. While the company has strong revenue growth and is positioned well in the AI infrastructure space, the recent price target reductions, higher operating expenses, and lower gross margins present challenges. Additionally, the technical indicators and options data suggest a lack of immediate upward momentum. For a long-term investor, it may be better to wait for a more favorable entry point or clearer positive signals.
The stock is in a bearish trend with the MACD histogram at -1.732 (below 0), RSI_6 at 31.724 (neutral zone), and bearish moving averages (SMA_200 > SMA_20 > SMA_5). The price is below the pivot support level of 131.434, with key support at 119.443 and resistance at 143.425. The stock has a 70% chance to decline by -4.34% in the next day and -2.57% in the next month.
Strong revenue growth in Q4 2025, up 91.77% YoY.
Positive AI infrastructure positioning with Amazon's $6.5B warrant agreement reinforcing long-term demand visibility.
Hedge funds are significantly increasing their positions in the stock, with a 678.70% increase in buying over the last quarter.
Lower gross margins and higher operating expenses are impacting profitability.
Recent price target reductions from JPMorgan and Citi reflect concerns about margin pressures and operational costs.
Technical indicators and price trends suggest bearish momentum.
No recent insider or congressional trading activity to provide additional confidence.
In Q4 2025, revenue increased by 91.77% YoY to $270.58M, indicating strong growth. However, net income dropped to $0 (-100% YoY), and EPS rose to 1.22 (+713.33% YoY). Gross margin improved slightly to 75.57% (+2.08% YoY), but higher operating expenses are a concern.
Analysts have mixed views. JPMorgan lowered its price target to $205 (from $215) but maintains an Overweight rating. BofA raised its target to $200 (from $185) with a Neutral rating, citing long-term demand visibility but highlighting margin pressures. Citi lowered its target to $250 (from $275) while maintaining a Buy rating. Overall, analysts acknowledge strong AI demand but are cautious about margin and expense challenges.
